본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice

이용수 0

영문명
Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice
발행기관
대한생리학회-대한약리학회
저자명
Qian Zhu Qu Zhou Xiao-li Luo Xu-jie Zhang San-yu Li
간행물 정보
『The Korean Journal of Physiology & Pharmacology』제27권 제3호, 221~230쪽, 전체 10쪽
주제분류
의약학 > 의학일반
파일형태
PDF
발행일자
2023.05.31
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Diabetic kidney disease is one of the most serious complications of diabetes. Although diabetic kidney disease can be effectively controlled through strict blood glucose management and corresponding symptomatic treatment, these therapies cannot reduce its incidence in diabetic patients. The sodium-glucose cotransporter 2 (SGLT2) inhibitors and the traditional Chinese herb “Gegen” have been widely used in diabetes-related therapy. However, it remains unclear whether the combined use of these two kinds of medicines contributes to an increased curative effect on diabetic kidney disease. In this study, we examined this issue by evaluating the efficacy of the combination of puerarin, an active ingredient of Gegen, and canagliflozin, an SGLT2 inhibitor for a 12-week intervention using a mouse model of diabetes. The results indicated that the combination of puerarin and canagliflozin was superior to canagliflozin alone in improving the metabolic and renal function parameters of diabetic mice. Our findings suggested that the renoprotective effect of combined puerarin and canagliflozin in diabetic mice was achieved by reducing renal lipid accumulation. This study provides a new strategy for the clinical prevention and treatment of diabetic kidney disease. The puerarin and SGLT2 inhibitor combination therapy at the initial stage of diabetes may effectively delay the occurrence of diabetic kidney injury, and significantly alleviate the burden of renal lipotoxicity.

목차

INTRODUCTION
METHODS
RESULTS
DISCUSSION
FUNDING
ACKNOWLEDGEMENTS
CONFLICTS OF INTEREST
SUPPLEMENTARY MATERIALS
REFERENCES

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

Qian Zhu, Qu Zhou, Xiao-li Luo, Xu-jie Zhang, San-yu Li. (2023).Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice. The Korean Journal of Physiology & Pharmacology, 27 (3), 221-230

MLA

Qian Zhu, Qu Zhou, Xiao-li Luo, Xu-jie Zhang, San-yu Li. "Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice." The Korean Journal of Physiology & Pharmacology, 27.3(2023): 221-230

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제